Navigation Links
VaxGen Issues Rebuttal to MedCap Letter
Date:3/25/2008

he ISS estimated liquidation outcome is not supportive of MedCap's position and, consequently, not referenced by MedCap.

MedCap's selective use of these third party sources is especially disturbing because they are based on limited distribution reports, usually only available to professional investors. Hence, MedCap's selective use of such information could easily mislead many or most of VaxGen's stockholders who do not have access to the full text of those reports. The ISS recommendations and their rationale are discussed in the addendum to this letter.

VaxGen believes these recent communications from MedCap show a flagrant disregard for accuracy. We have reason to believe that MedCap has made even more inaccurate and misleading claims in its conversations with other stockholders and third parties. We can only conclude that MedCap cares not about the truth; but rather about defeating the proposed merger at any cost.

In summary, MedCap and its principals have apparently determined to sway the VaxGen-Raven merger vote any way they can. VaxGen believes this includes the use of flawed arguments as well as false and misleading information. As the CEO of VaxGen, I urge stockholders to examine the facts objectively. If you do so, I continue to believe the correct outcome is to vote "Yes" in favor of the merger.

Sincerely,

James P. Panek

President and CEO

VaxGen, Inc.

Detailed Discussion Regarding Financial and Liquidation Claims; ISS Recommendations

MedCap's Financial Analysis is both Incorrect and Shallow.

MedCap represents that VaxGen spent $56.1 million in 2007, or $40.1 million, before impairments or restructuring. In fact, neither of these figures (which are drawn from the profit and loss account) are accurate representations of the Company's cash burn in 2007. The best measure of this is to be found in the Consolidated Statements of Cash Flows on page 39 of the Company's 2007 Annual Report
'/>"/>

SOURCE VaxGen Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. VaxGen Files 2006 Financial Statements and Provides Cash Update
2. VaxGen Further Restructures to Preserve Cash as It Pursues Strategic Initiatives
3. VaxGen Files First Quarter 2007 Financials
4. Jack Anthony to Resign From VaxGens Board After Accepting CEO Position at Osprey Pharmaceuticals
5. VaxGen Files Last Outstanding Periodic Report With SEC
6. VaxGen Addresses MPM Claims in Letter to Stockholders
7. VaxGen Common Stock Expected to Qualify for Quotation on OTC Bulletin Board
8. VaxGen Stockholders Overwhelmingly Approve Reverse Split Proposal
9. VaxGen and Raven Announce Form S4 Registration Statement Declared Effective
10. VaxGen to Present at the 10th Annual BIO CEO and Investor Conference
11. VaxGen Reports Financial Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... , April 1, 2015 /PRNewswire/ - Portage ... Exchange: PBT.U), is pleased to announce that Biohaven ... 54% equity, has entered into an agreement with ... first clinical trial with their lead compound (BHV-0223). ... identification and development of clinical stage neuroscience compounds ...
(Date:4/1/2015)... 1, 2014 /CNW/ - Canada,s Research-Based ... (PMPRB) newly released report on Cost Drivers of Public Drug ... according to the report, the rates of change in drug ... low of -0.8 percent in 2012/13 for a number of ... that examines the costs of medicines without considering their overall ...
(Date:4/1/2015)... April 01, 2015 Holomic is introducing ... read both chromatographic and fluorescent rapid tests with one ... high performance, quantitative readers and is already selling its ... is a first of its kind offering for manufacturers ... , Dr. Neven Karlovac, CEO of Holomic LLC, ...
(Date:4/1/2015)... National recruitment firm Slone Partners ... Allen as Head of Sales at Optimal Medicine, an ... , Allen brings over 20 years experience in ... number of companies including Dell Services Healthcare, Medsphere Systems ... a perfect fit for accomplishing the goals Optimal Medicine ...
Breaking Biology Technology:Portage's Biohaven Announces Agreement with inVentiv Health 2Portage's Biohaven Announces Agreement with inVentiv Health 3Rx&D responds to PMPRB report: overall impact of medicines must always be considered 2Holomic to Introduce the First Dual, Chromatographic and Fluorescent Rapid Test Reader, the HRDR-400 2Slone Partners Fills Head of Sales at Optimal Medicine 2
... ... Proprietary PatentRatings® System,World’s Most Inventive Companies Are Ranked Based on Patent Quality, Not Quantity ... Chicago, IL ... announced the results of a proprietary study performed for Bloomberg BusinessWeek. , , , ...
... LEXINGTON, Ky. , Jan. 19 VirtualHealth ... will be changing its name to VHGI Holdings, Inc. to ... to Jim Renfro , VHGI President, "This name change ... our company,s commitment on asset diversification and creating more value ...
... Ruptured ... emergency repair of ruptured AAA could save more lives in some cases than traditional open ... 22nd annual International Symposium on Endovascular Therapy (ISET). , ... Hollywood, FL (PRWEB) January 18, 2010 -- Ruptured abdominal ...
Cached Biology Technology:Ocean Tomo Study Ranks Top 25 Most Inventive Companies for Bloomberg BusinessWeek, 2Ocean Tomo Study Ranks Top 25 Most Inventive Companies for Bloomberg BusinessWeek, 3Ocean Tomo Study Ranks Top 25 Most Inventive Companies for Bloomberg BusinessWeek, 4VirtualHealth Technologies Will Change Its Name to VHGI Holdings, Inc. and Surges Forward Into Broader Market 2VirtualHealth Technologies Will Change Its Name to VHGI Holdings, Inc. and Surges Forward Into Broader Market 3Minimally Invasive Repair of Ruptured Aortic Aneurysm Could Save More Lives than Surgery 2Minimally Invasive Repair of Ruptured Aortic Aneurysm Could Save More Lives than Surgery 3Minimally Invasive Repair of Ruptured Aortic Aneurysm Could Save More Lives than Surgery 4Minimally Invasive Repair of Ruptured Aortic Aneurysm Could Save More Lives than Surgery 5
(Date:3/30/2015)... 26, 2015 Research and Markets ( ... "Global Gesture Recognition Market in Automotive Sector 2014-2018" ... the Global Gesture Recognition market in Automotive Sector to ... 2013-2018. Gesture recognition is the ability of ... of an individual. Gesture recognition technology can be 2D-based ...
(Date:3/24/2015)... , March 24, 2015   Crossmatch ™, ... today announced that its U.are.U ® 4500 ... Goorin Bros . to achieve PCI compliance ... secures access to the POS terminal, protecting the ... of data breaches. With one-third ...
(Date:3/20/2015)... , Mar. 20, 2015 Research and Markets ... addition of the "India Sensors Market Forecast ... The sensor market is projected to ... Consumer electronics, automotive, industrial and healthcare ... in the country. In addition, adoption of MEMS ...
Breaking Biology News(10 mins):Global Gesture Recognition Market in Automotive Sector Report 2015 - Growing Number of Partnerships 2Crossmatch Fingerprint Readers Help Retailer Prevent Data Breaches at Point-of-Sale 2India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 2India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 3
... of international molecular scientists, led by a Monash University researcher ... change for example their location during spreading of a ... The discovery sheds new light on cell behaviour and could ... such as cancer, rheumatoid arthritis and Alzheimer,s disease. The ...
... A study published in Science and reviewed by ... our brains have the amazing ability to be energy efficient. ... action potentials, by controlling the flow of positive sodium and ... ion equilibrium after an action potential requires energy. ...
... (EPA) will celebrate its 40th birthday in 2010, but ... of nationally recognized experts in environmental science, technology, and ... integrated approach to environmental protection that accounts for the ... article to be published in the December issue of ...
Cached Biology News:Milestone discovery in cell behaviors 2
... (OSM) is a pleiotropic cytokine produced by ... cells. OSM inhibits the growth of some ... smooth muscle and Kaposis sarcoma cell proliferation, ... density lipoprotein receptor expression on hepatoma cells. ...
... isopropyl ester (15(R)-17-phenyl trinor PGF2α isopropyl ... both a double bond at 13,14 ... at C-15. Similar to 15(S)-latanoprost, 15(R)-17-phenyl ... potential impurity in most commercial preparations ...
ACS Reagent Grade C 19 H 14 O 5 S Formula Weight: 354.38 PRODUCT SPECIFICATIONS Form: Rust/red crystalline powder Clarity of Solution: Passes test Visual Transition Interval: pH 6.8 - Yellow pH 8.2...
... Nop1p/Fibrillarin (monoclonal) Nop1p/Fibrillarin was ... of bakers yeast, Saccharomyces cerevisiae (accession ... for yeast viability and is localized ... of Nop1p is fibrillarin (accession P22087) ...
Biology Products: